The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 25, 2018

Filed:

Jun. 17, 2015
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Washington, DC (US);

Inventors:

Stephen S. Whitehead, Bethesda, MD (US);

Joseph E. Blaney, Gettysburg, PA (US);

Brian R. Murphy, Bethesda, MD (US);

Ching-Juh Lai, Bethesda, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/04 (2006.01); C12N 7/00 (2006.01); C07K 14/18 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/045 (2013.01); C07K 14/005 (2013.01); C07K 14/1825 (2013.01); C12N 7/00 (2013.01); A61K 2039/5254 (2013.01); C12N 2770/24122 (2013.01); C12N 2770/24162 (2013.01); Y02A 50/386 (2018.01);
Abstract

The invention is related to a dengue virus or chimeric dengue virus that contains a mutation in the 3' untranslated region (3′-UTR) comprising a Δ30 mutation that removes the TL-2 homologous structure in each of the dengue virus serotypes 1, 2, 3, and 4, and nucleotides additional to the Δ30 mutation deleted from the 3′-UTR that removes sequence in the 5′ direction as far as the 5′ boundary of the TL-3 homologous structure in each of the dengue virus serotypes 1, 2, 3, and 4, or a replacement of the 3′-UTR of a dengue virus of a first serotype with the 3′-UTR of a dengue virus of a second serotype, optionally containing the Δ30 mutation and nucleotides additional to the Δ30 mutation deleted from the 3′-UTR; and immunogenic compositions, methods of inducing an immune response, and methods of producing a dengue virus or chimeric dengue virus.


Find Patent Forward Citations

Loading…